Liposomal Bupivacaine Use in Alveolar Bone Graft Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 24, 2024

Primary Completion Date

April 24, 2026

Study Completion Date

April 24, 2026

Conditions
Cleft Lip and Palate
Interventions
DRUG

Liposomal Bupivacaine

Patients will receive liposomal bupivacaine mixed with epinephrine (ratio of 1:100,000) for pain management after surgery.

DRUG

Bupivacain

Patients will receive standard bupivacaine mixed with epinephrine (ratio of 1:100,000) for pain management after surgery.

DRUG

Epinephrine

Patients will receive epinephrine (ratio of 1:100,000) mixed with the appropriate drug assigned to them based on their arm.

Trial Locations (1)

60707

RECRUITING

Shriners Children's Chicago, Chicago

All Listed Sponsors
collaborator

Shriners Hospitals for Children

OTHER

lead

Kerry O'Rourke

OTHER